Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Holmberg

Showing results (221-230 of 256) with videos related to

Pageof 26
Sort By:
Transfusion|February 24, 2017
First cases of Zika virus-infected US blood donors outside states with areas of active transmissionPhillip C Williamson, Jeffrey M Linnen, Debra A Kessler, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Gene discovery in the wood-forming tissues of poplar: analysis of 5, 692 expressed sequence tagsF Sterky, S Regan, J Karlsson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Leukemia & Lymphoma|April 9, 2014
Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivityColin Phipps, Ajay K Gopal, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2003
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseasesRichard A Nash, Roger Dansey, Jan Storek, et al.
Cell|August 21, 2010
Identification of MOAG-4/SERF as a regulator of age-related proteotoxicityTjakko J van Ham, Mats A Holmberg, Annemieke T van der Goot, et al.
Journal of Hematology & Oncology|June 30, 2018
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantationRobert W Chen, Joycelynne M Palmer, Sarah Tomassetti, et al.
The Journal of Clinical Investigation|December 13, 2022
TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in miceSimone A Minnie, Olivia G Waltner, Kathleen S Ensbey, et al.
Blood|August 15, 2002
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomesPeter A McSweeney, Richard A Nash, Keith M Sullivan, et al.
Pageof 26

Showing results (221-230 of 256) with videos related to

Sort By:
Pageof 26
Transfusion|February 24, 2017
First cases of Zika virus-infected US blood donors outside states with areas of active transmissionPhillip C Williamson, Jeffrey M Linnen, Debra A Kessler, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Gene discovery in the wood-forming tissues of poplar: analysis of 5, 692 expressed sequence tagsF Sterky, S Regan, J Karlsson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 3, 2024
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm TrialGeorge E Georges, Dinesh Khanna, Mark H Wener, et al.
Bone Marrow Transplantation|November 18, 1998
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancerL A Holmberg, T Demirer, S Rowley, et al.
Leukemia & Lymphoma|April 9, 2014
Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivityColin Phipps, Ajay K Gopal, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2003
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseasesRichard A Nash, Roger Dansey, Jan Storek, et al.
Cell|August 21, 2010
Identification of MOAG-4/SERF as a regulator of age-related proteotoxicityTjakko J van Ham, Mats A Holmberg, Annemieke T van der Goot, et al.
Journal of Hematology & Oncology|June 30, 2018
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantationRobert W Chen, Joycelynne M Palmer, Sarah Tomassetti, et al.
The Journal of Clinical Investigation|December 13, 2022
TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in miceSimone A Minnie, Olivia G Waltner, Kathleen S Ensbey, et al.
Blood|August 15, 2002
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomesPeter A McSweeney, Richard A Nash, Keith M Sullivan, et al.
Pageof 26